Literature DB >> 22361087

Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.

Matteo Morotti1, Mario Valenzano Menada, Melita Moioli, Paolo Sala, Ilaria Maffeo, Luca Abete, Ezio Fulcheri, Stefania Menoni, Pierluigi Venturini, Andrea Papadia.   

Abstract

OBJECTIVES: A significant number of women diagnosed with atypical endometrial hyperplasia (AEH) on endometrial biopsy will be diagnosed with endometrial cancer (EC) on the hysterectomy specimen at permanent section. Surgical treatment for AEH and EC differ substantially. We have assessed the concordance in EC between frozen and permanent sections on patients undergoing hysterectomy for AEH.
MATERIALS AND METHODS: A retrospective review of 66 frozen sections on patients undergoing hysterectomy for AEH was performed. Frozen and permanent section diagnoses were categorized as negative or positive for malignancy. Permanent section carcinomas were classified as low or high risk based on their histopathology, myometrial invasion and differentiation. Correlation between frozen and permanent section and sensitivity, specificity, PPV, NPV and accuracy of frozen section in predicting EC in permanent section were calculated. Likelihood of diagnosing EC on frozen section was compared based on risk stratification at permanent section.
RESULTS: Frozen and permanent sections revealed malignancy in 43.9% and 56% of the patients respectively. 94.1% of high risk carcinomas were identified as EC at frozen section as compared to 55% of low risk EC. Concordance was good (κ=0.75). Sensitivity, specificity, NPV, PPV and accuracy in predicting EC at frozen section were 73%, 93.1%, 73% and 93.1% respectively. Carcinomas were detected at frozen section significantly more often if they were at high risk.
CONCLUSIONS: The substantial agreement between frozen and permanent sections allows minimizing under- and overtreatment of women undergoing hysterectomy for AEH. High risk EC are efficiently identified in frozen section.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22361087     DOI: 10.1016/j.ygyno.2012.02.011

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

Review 1.  Surgical staging in endometrial cancer.

Authors:  Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-11-20       Impact factor: 4.553

Review 2.  Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-21       Impact factor: 4.553

3.  Does Obesity Affect Pathologic Agreement of Initial and Final Tumor Grade of Disease in Endometrial Cancer Patients?

Authors:  Laura R Daily; Jonathan D Boone; Hannah C Machemehl; Eric D Thomas; Gerald McGwin; J Michael Straughn; Charles A Leath
Journal:  Int J Gynecol Cancer       Date:  2017-05       Impact factor: 3.437

4.  FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?

Authors:  Andrea Papadia; Maria Luisa Gasparri; Franziska Siegenthaler; Sara Imboden; Stefan Mohr; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-11       Impact factor: 4.553

5.  Does Preoperative Diagnosis of Endometrial Hyperplasia Necessitate Intraoperative Frozen Section Consultation?

Authors:  Gokhan Boyraz; Derman Başaran; Mehmet C Salman; Nejat Özgül; Kunter Yüce
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

6.  Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Anda P Radan; Chantal A L Stämpfli; Tilman T Rau; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-24       Impact factor: 4.553

7.  The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer.

Authors:  Andrea Papadia; Alessandro Buda; Maria Luisa Gasparri; Giampaolo Di Martino; Beatrice Bussi; Debora Verri; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-24       Impact factor: 4.553

8.  Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough?

Authors:  Andrea Papadia; Sara Imboden; Maria Luisa Gasparri; Franziska Siegenthaler; Anja Fink; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-18       Impact factor: 4.553

9.  Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia.

Authors:  Pinar Kadirogullari; Cemal Resat Atalay; Ozhan Ozdemir; Mustafa Erkan Sari
Journal:  J Clin Diagn Res       Date:  2015-10-01

10.  Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.

Authors:  Andrea Papadia; Sara Imboden; Franziska Siegenthaler; Maria Luisa Gasparri; Stefan Mohr; Susanne Lanz; Michael D Mueller
Journal:  Ann Surg Oncol       Date:  2016-01-20       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.